Poster presented at Clinical Immunology Meeting (CIS) April 2021

16 Apr, 2021 – Virtual Meeting (April 16, 2021) – Dr Richard Wasserman presented results from the completed PlasmaCap IG Phase III Clinical Trial entitled “Efficacy and Safety of PlasmaCap IG, a New 10% Intravenous Immunoglobulin Manufactured Using an Innovative Chromatography Process, In Adults and Children with Primary Immunodeficiency Disorders”. Abstracts available here